Amring Pharmaceuticals Inc., a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, 60 pack of 0.3mL unit dose vials and has begun commercialization activities.
Oregon Bioscience Association releases its new economic impact report at https://www.oregonbio.org/about/reports/ which points to continued robust growth during the pandemic, with combined economic impacts far outpacing Oregons overall economy. PORTLAND, Ore. This press release features multimedia.
Results in PSGs latest research indicate a growing interest in disrupting the status quo relative to specialty drug management Extensive research about the latest trends in specialty benefit design launches today. This press release features multimedia.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
Log In Required
Line of Credit Log In Required